Jeffrey W. Sherman - 01 Jul 2021 Form 4 Insider Report for Horizon Therapeutics Public Ltd Co

Role
EVP and Chief Medical Officer
Signature
/s/ Miles W. McHugh, Attorney-in-Fact
Issuer symbol
N/A
Transactions as of
01 Jul 2021
Net transactions value
-$5,707,362
Form type
4
Filing time
02 Jul 2021, 17:02:48 UTC
Previous filing
08 Jun 2021
Next filing
30 Jul 2021
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction HZNP Ordinary Shares Gift $0 -66,730 -82% $0.000000 14,402 10 Mar 2021 Direct F1
transaction HZNP Ordinary Shares Gift $0 +66,730 $0.000000 66,730 10 Mar 2021 By Spouse
transaction HZNP Ordinary Shares Sale $502,265 -5,287 -37% $95.00 9,115 01 Jul 2021 Direct F2
transaction HZNP Ordinary Shares Sale $5,205,097 -54,789 -30% $95.00 128,845 01 Jul 2021 By Trust F2, F3
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Includes 1,049 ordinary shares of the Issuer acquired by the reporting person on June 1, 2021 pursuant to an employee stock purchase program.
F2 The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on March 12, 2021.
F3 The reported price in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $95.00 to $95.05 per share, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.